Principal Healthcare Innovators ETF Rating → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free BTEC Stock Alerts $36.19 -0.84 (-2.27%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestSocial MediaStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestSocial Media Principal Healthcare Innovators ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BTEC Aggregate RatingModerate Buy2.71Holdings in BTEC have an aggregate rating of Moderate Buy based on 516 analyst ratings issued in the past year covering 50 companies (60.5% of the portfolio).BTEC Aggregate Price Target$48.0632.79% UpsideHigh Prediction$66.32Average Prediction$48.06Low Prediction$32.24Holdings in BTEC have an aggregate price target of $48.06 and a range of $32.24 to $66.32 covering 50 companies (60.5% of the portfolio).BTEC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Principal Healthcare Innovators ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BTEC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.70%MRNAModerna$122.80+0.7%4 of 5 stars2.25$126.89 3.3%16Earnings ReportAnalyst ForecastAnalyst Revision3.16%ALNYAlnylam Pharmaceuticals$152.29-1.3%5 of 5 stars2.59$216.19 42.0%17Earnings ReportAnalyst Forecast2.84%ILMNIllumina$110.62-2.0%5 of 5 stars2.30$164.65 48.8%20Earnings ReportAnalyst ForecastAnalyst Revision2.58%SRPTSarepta Therapeutics$132.58-2.5%4 of 5 stars2.79$160.60 21.1%14Insider SellingAnalyst Revision2.39%NTRANatera$94.00-1.7%2 of 5 stars3.00$86.40 -8.1%14Upcoming Earnings2.31%EXASExact Sciences$59.48-3.1%4 of 5 stars2.92$99.07 66.6%13News Coverage2.15%CTLTCatalent$54.85-2.4%3 of 5 stars2.15$52.46 -4.4%13News Coverage1.92%ROIVRoivant Sciences$11.16-0.4%4 of 5 stars2.90$16.90 51.4%10Positive News1.75%VKTXViking Therapeutics$80.00+0.1%4 of 5 stars3.00$112.25 40.3%101.64%CERECerevel Therapeutics$42.06-0.5%0 of 5 stars2.11$42.67 1.4%9Positive News1.58%INSPInspire Medical Systems$165.00+1.0%5 of 5 stars2.69$256.53 55.5%16Earnings ReportAnalyst DowngradeAnalyst RevisionNews CoverageGap Down1.48%PCVXVaxcyte$66.79-1.1%1 of 5 stars3.00$78.50 17.5%4Upcoming EarningsAnalyst ForecastNews Coverage1.45%ITCIIntra-Cellular Therapies$67.00-5.9%5 of 5 stars2.90$90.17 34.6%10Earnings ReportAnalyst ForecastAnalyst Revision1.41%CYTKCytokinetics$65.270.0%4 of 5 stars2.87$79.33 21.5%15Analyst ForecastInsider SellingNews Coverage1.41%ELANElanco Animal Health$16.89+24.9%3 of 5 stars2.57$16.71 -1.0%7News CoverageGap UpHigh Trading Volume1.40%BPMCBlueprint Medicines$108.78+0.2%1 of 5 stars2.50$100.31 -7.8%16Analyst ForecastInsider SellingAnalyst Revision1.38%RVMDRevolution Medicines$38.31-1.5%3 of 5 stars3.10$41.20 7.5%10Gap Down1.34%IONSIonis Pharmaceuticals$40.16-1.9%4 of 5 stars2.71$59.54 48.3%14Earnings ReportAnalyst ForecastInsider SellingNews CoveragePositive News1.31%IBRXImmunityBio$7.99+0.9%0 of 5 stars2.00$6.00 -24.9%1Gap Down1.22%APLSApellis Pharmaceuticals$42.30-3.6%4 of 5 stars2.87$76.67 81.2%15Earnings ReportAnalyst ForecastAnalyst Revision1.11%GKOSGlaukos$106.91-1.0%4 of 5 stars2.82$108.64 1.6%11Analyst UpgradeInsider Selling1.09%BBIOBridgeBio Pharma$27.70-0.3%5 of 5 stars2.80$47.82 72.6%100.93%ALPNAlpine Immune Sciences$64.70+0.1%2 of 5 stars2.27$50.33 -22.2%110.92%MDGLMadrigal Pharmaceuticals$208.04-4.6%5 of 5 stars2.73$351.45 68.9%11Earnings ReportAnalyst ForecastNews CoverageGap Down0.91%NUVLNuvalent$67.54-1.6%3 of 5 stars2.90$90.78 34.4%10Insider SellingNews Coverage0.90%IMVTImmunovant$29.76+0.6%3 of 5 stars3.00$48.00 61.3%17Positive News0.90%TMDXTransMedics Group$125.81-1.1%2 of 5 stars2.88$119.00 -5.4%8Insider Selling0.82%INSMInsmed$26.00-0.3%4 of 5 stars3.00$44.92 72.8%12Analyst DowngradeNews Coverage0.79%CRNXCrinetics Pharmaceuticals$50.89+6.8%4 of 5 stars2.92$57.58 13.2%12Analyst ForecastNews CoverageGap UpHigh Trading Volume0.77%IOVAIovance Biotherapeutics$13.39-4.2%5 of 5 stars3.00$24.64 84.0%10Options Volume0.77%RAREUltragenyx Pharmaceutical$41.48-0.2%4 of 5 stars2.92$87.85 111.8%12Earnings ReportAnalyst Forecast0.76%AXSMAxsome Therapeutics$75.68-1.6%4 of 5 stars2.92$121.92 61.1%13Analyst ForecastAnalyst RevisionNews Coverage0.74%IRTCiRhythm Technologies$98.76-7.0%1 of 5 stars3.00$134.00 35.7%70.72%JANXJanux Therapeutics$55.41+0.1%3 of 5 stars3.00$61.33 10.7%7Analyst ForecastGap Down0.70%BHVNBiohaven$40.69-0.2%3 of 5 stars3.00$52.13 28.1%8Upcoming Earnings0.69%SWTXSpringWorks Therapeutics$42.26-7.6%1 of 5 stars3.00$68.83 62.9%6Earnings ReportAnalyst ForecastAnalyst Revision0.69%PRCTPROCEPT BioRobotics$60.36-3.9%1 of 5 stars3.00$61.20 1.4%7Analyst ForecastInsider SellingAnalyst Revision0.67%IDYAIDEAYA Biosciences$41.41-3.1%3 of 5 stars3.00$47.50 14.7%12Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Down0.67%FOLDAmicus Therapeutics$10.14-2.7%4 of 5 stars3.00$20.00 97.2%3News Coverage0.65%ARWRArrowhead Pharmaceuticals$25.22+0.9%4 of 5 stars2.64$50.80 101.4%110.64%AZTAAzenta$54.07-1.9%2 of 5 stars2.33$69.60 28.7%6News Coverage0.62%ENOVEnovis$50.55-3.2%3 of 5 stars3.00$75.43 49.2%8Earnings ReportAnalyst Revision0.62%SMMTSummit Therapeutics$4.92-0.8%2 of 5 stars3.00$7.50 52.4%2Analyst Forecast0.61%ACLXArcellx$52.25-0.3%3 of 5 stars3.00$75.64 44.8%12Upcoming EarningsAnalyst Forecast0.60%TXG10x Genomics$25.32-0.2%4 of 5 stars2.58$48.50 91.5%12Gap Down0.58%CLDXCelldex Therapeutics$41.21-2.4%1 of 5 stars2.80$66.00 60.2%5Analyst ForecastAnalyst RevisionNews Coverage0.57%CGONCG Oncology$32.43-4.5%1 of 5 stars2.75$61.75 90.4%4Analyst Forecast0.57%PTCTPTC Therapeutics$31.14-2.0%2 of 5 stars1.92$33.67 8.1%13Gap Down0.56%TGTXTG Therapeutics$17.12-0.3%4 of 5 stars2.83$29.83 74.3%6Analyst Revision0.54%RYTMRhythm Pharmaceuticals$38.92-1.1%3 of 5 stars2.83$54.33 39.6%6Earnings ReportAnalyst ForecastNews CoverageGap Down This page (NASDAQ:BTEC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Principal Healthcare Innovators ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
